BTK inhibitors as potential therapies for multiple sclerosis

Correale, Jorge

dc.contributor.author	Correale, Jorge
dc.date.accessioned	2021-09-15T17:00:14Z
dc.date.available	2021-09-15T17:00:14Z
dc.date.issued	2021-08-19
dc.identifier.citation	Correale J. BTK inhibitors as potential therapies for multiple sclerosis. Lancet Neurol. 2021 Sep;20(9):689-691. doi: 10.1016/S1474-4422(21)00250-7	es_ES
dc.identifier.uri	https://doi.org/10.1016/S1474-4422(21)00250-7
dc.identifier.uri	https://repositorio.fleni.org.ar/xmlui/handle/123456789/586
dc.description.abstract	Resumen no disponible	es_ES
dc.language.iso	eng	es_ES
dc.publisher	Elsevier	es_ES
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	https://creativecommons.org/licenses/by/2.5/ar/
dc.subject	Multiple Sclerosis	es_ES
dc.subject	Esclerosis Múltiple	es_ES
dc.subject	Protein Kinase Inhibitors	es_ES
dc.subject	Inhibidores de Proteínas Quinasas	es_ES
dc.title	BTK inhibitors as potential therapies for multiple sclerosis	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.type	info:eu-repo/semantics/publishedVersion
dc.description.fil	Fil: Correale, Jorge. Fleni. Departamento de Neurología. Servicio de Neuroinmunología y Enfermedades Desmielinizantes; Argentina.
dc.relation.ispartofVOLUME	20
dc.relation.ispartofNUMBER	9
dc.relation.ispartofPAGINATION	689-691
dc.relation.ispartofCOUNTRY	Reino Unido
dc.relation.ispartofCITY	Londres
dc.relation.ispartofTITLE	The Lancet. Neurology
dc.relation.ispartofISSN	1474-4465
dc.type.snrd	info:ar-repo/semantics/artículo	es_ES